Observation of Safety and Efficacy of Botulinum Toxin Type A in the Treatment of Tear Troughs and Mild Yelid Bags
Journal of Cosmetic Dermatology · 2025-06 · 24 (6)
DOI: 10.1111/jocd.70253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 04.06.2025. Verfasst von Siyuan Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Cosmetology, Second Affiliated Hospital of Guangxi Medical University, Nanning City, Guangxi Province, China. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Skin Aging, Cosmetic Techniques, Neuromuscular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the safety and efficacy of Botulinum Toxin Type A (BTX‐A) injection for the treatment of tear troughs.
Method
This study included patients with tear troughs rated as Grade 1–2 on the Barton Aesthetic Scale, who were treated between September 2023 and September 2024. These patients underwent intradermal injections of Botulinum Toxin Type A (BTX‐A). Doctors conducted pre‐ and post‐procedure assessments of the severity of tear troughs using the Barton Scale and TTRS (The Tear Trough Rating Scale). VISIA skin image analyzer (Canfield, USA) was utilized to compare the number of wrinkles, and facial scores and percentiles were calculated for objective evaluations before and after treatment. Additionally, doctors employed the Fitzpatrick Scale to assess periorbital wrinkles. This investigation was conducted as a prospective single‐center study (PSS).
Results
All 42 patients completed the study. After treatment, there was a significant improvement in VISIA‐measured wrinkle count, facial scores, and percentiles. Additionally, there were significant reductions in Barton, TTRS, and Fitzpatrick scores. One case of pseudo‐eyelid bags was observed post‐treatment, while no other complications such as diplopia, lower eyelid skin laxity, or other adverse effects were reported.
Conclusion
BTX‐A is effective in improving mild tear troughs while simultaneously reducing fine lines in the lower eyelid. Patients were highly satisfied with the improved appearance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Cosmetology, Second Affiliated Hospital of Guangxi Medical University, Nanning City, Guangxi Province, China.
- Guangxi Medical University, Nanning City, Guangxi Province, China.
- Guangxi Health Science College, Nanning City, Guangxi Province, China.
- The Second Affiliated Hospital of Guangxi Medical University, Nanning City, Guangxi Province, China.
ORCID-Profile: Homgtao Liu
Zitieren
APA
Zhou, S., Liu, H., Pan, Z., Pan, F., Liang, Q., Qiu, H., Wu, B., Zhang, L., & Zhou, X. (2025). Observation of Safety and Efficacy of Botulinum Toxin Type A in the Treatment of Tear Troughs and Mild Yelid Bags. Journal of Cosmetic Dermatology, 24(6). https://doi.org/10.1111/jocd.70253
Vancouver
Zhou S, Liu H, Pan Z, Pan F, Liang Q, Qiu H, et al. Observation of Safety and Efficacy of Botulinum Toxin Type A in the Treatment of Tear Troughs and Mild Yelid Bags. Journal of Cosmetic Dermatology. 2025;24(6). doi:10.1111/jocd.70253
BibTeX
@article{Zhou2025,
author = {Zhou, Siyuan and Liu, Homgtao and Pan, Zhongjie and Pan, Fuqiang and Liang, Qian and Qiu, Houhuang and Wu, Bingliang and Zhang, Liming and Zhou, Xiang},
title = {Observation of Safety and Efficacy of Botulinum Toxin Type A in the Treatment of Tear Troughs and Mild Yelid Bags},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
volume = {24},
number = {6},
doi = {10.1111/jocd.70253}
}
EUVIMED